ANTI-GLYPICAN 3 ANTIBODY
An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the pre...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | TANAKA, MEGUMI KINOSHITA, YASUKO NEZU, JUN-ICHI KONISHI, HIROKO ISHIGURO, TAKAHIRO SUGO, IZUMI YOSHINO, TAKESHI IGAWA, TOMOYUKI KAWAI, SHIGETO NAKANO, KIYOTAKA TSUNODA, HIROYUKI |
description | An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present invention is useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers.
Anticorps capable de se lier à une région spécifique du glypican 3 et anticorps humanisé élaboré à partir de l'anti-corps ci-dessus. L'anticorps anti-GPC3 décrit ci-dessus, qui a des activités ADCC et CDC élevées comparées aux anticorps existants, est utile en tant qu'inhibiteur de prolifération de cellule, en tant qu'agent anticancéreux, et dans le diagnostic du cancer. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2544692C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2544692C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2544692C3</originalsourceid><addsrcrecordid>eNrjZJBw9Avx1HX3iQzwdHb0UzBWAPGd_F0ieRhY0xJzilN5oTQ3g7yba4izh25qQX58anFBYnJqXmpJvLOjkamJiZmlkbMxYRUAZhoeog</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-GLYPICAN 3 ANTIBODY</title><source>esp@cenet</source><creator>TANAKA, MEGUMI ; KINOSHITA, YASUKO ; NEZU, JUN-ICHI ; KONISHI, HIROKO ; ISHIGURO, TAKAHIRO ; SUGO, IZUMI ; YOSHINO, TAKESHI ; IGAWA, TOMOYUKI ; KAWAI, SHIGETO ; NAKANO, KIYOTAKA ; TSUNODA, HIROYUKI</creator><creatorcontrib>TANAKA, MEGUMI ; KINOSHITA, YASUKO ; NEZU, JUN-ICHI ; KONISHI, HIROKO ; ISHIGURO, TAKAHIRO ; SUGO, IZUMI ; YOSHINO, TAKESHI ; IGAWA, TOMOYUKI ; KAWAI, SHIGETO ; NAKANO, KIYOTAKA ; TSUNODA, HIROYUKI</creatorcontrib><description>An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present invention is useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers.
Anticorps capable de se lier à une région spécifique du glypican 3 et anticorps humanisé élaboré à partir de l'anti-corps ci-dessus. L'anticorps anti-GPC3 décrit ci-dessus, qui a des activités ADCC et CDC élevées comparées aux anticorps existants, est utile en tant qu'inhibiteur de prolifération de cellule, en tant qu'agent anticancéreux, et dans le diagnostic du cancer.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140401&DB=EPODOC&CC=CA&NR=2544692C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140401&DB=EPODOC&CC=CA&NR=2544692C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANAKA, MEGUMI</creatorcontrib><creatorcontrib>KINOSHITA, YASUKO</creatorcontrib><creatorcontrib>NEZU, JUN-ICHI</creatorcontrib><creatorcontrib>KONISHI, HIROKO</creatorcontrib><creatorcontrib>ISHIGURO, TAKAHIRO</creatorcontrib><creatorcontrib>SUGO, IZUMI</creatorcontrib><creatorcontrib>YOSHINO, TAKESHI</creatorcontrib><creatorcontrib>IGAWA, TOMOYUKI</creatorcontrib><creatorcontrib>KAWAI, SHIGETO</creatorcontrib><creatorcontrib>NAKANO, KIYOTAKA</creatorcontrib><creatorcontrib>TSUNODA, HIROYUKI</creatorcontrib><title>ANTI-GLYPICAN 3 ANTIBODY</title><description>An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present invention is useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers.
Anticorps capable de se lier à une région spécifique du glypican 3 et anticorps humanisé élaboré à partir de l'anti-corps ci-dessus. L'anticorps anti-GPC3 décrit ci-dessus, qui a des activités ADCC et CDC élevées comparées aux anticorps existants, est utile en tant qu'inhibiteur de prolifération de cellule, en tant qu'agent anticancéreux, et dans le diagnostic du cancer.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBw9Avx1HX3iQzwdHb0UzBWAPGd_F0ieRhY0xJzilN5oTQ3g7yba4izh25qQX58anFBYnJqXmpJvLOjkamJiZmlkbMxYRUAZhoeog</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>TANAKA, MEGUMI</creator><creator>KINOSHITA, YASUKO</creator><creator>NEZU, JUN-ICHI</creator><creator>KONISHI, HIROKO</creator><creator>ISHIGURO, TAKAHIRO</creator><creator>SUGO, IZUMI</creator><creator>YOSHINO, TAKESHI</creator><creator>IGAWA, TOMOYUKI</creator><creator>KAWAI, SHIGETO</creator><creator>NAKANO, KIYOTAKA</creator><creator>TSUNODA, HIROYUKI</creator><scope>EVB</scope></search><sort><creationdate>20140401</creationdate><title>ANTI-GLYPICAN 3 ANTIBODY</title><author>TANAKA, MEGUMI ; KINOSHITA, YASUKO ; NEZU, JUN-ICHI ; KONISHI, HIROKO ; ISHIGURO, TAKAHIRO ; SUGO, IZUMI ; YOSHINO, TAKESHI ; IGAWA, TOMOYUKI ; KAWAI, SHIGETO ; NAKANO, KIYOTAKA ; TSUNODA, HIROYUKI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2544692C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>TANAKA, MEGUMI</creatorcontrib><creatorcontrib>KINOSHITA, YASUKO</creatorcontrib><creatorcontrib>NEZU, JUN-ICHI</creatorcontrib><creatorcontrib>KONISHI, HIROKO</creatorcontrib><creatorcontrib>ISHIGURO, TAKAHIRO</creatorcontrib><creatorcontrib>SUGO, IZUMI</creatorcontrib><creatorcontrib>YOSHINO, TAKESHI</creatorcontrib><creatorcontrib>IGAWA, TOMOYUKI</creatorcontrib><creatorcontrib>KAWAI, SHIGETO</creatorcontrib><creatorcontrib>NAKANO, KIYOTAKA</creatorcontrib><creatorcontrib>TSUNODA, HIROYUKI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANAKA, MEGUMI</au><au>KINOSHITA, YASUKO</au><au>NEZU, JUN-ICHI</au><au>KONISHI, HIROKO</au><au>ISHIGURO, TAKAHIRO</au><au>SUGO, IZUMI</au><au>YOSHINO, TAKESHI</au><au>IGAWA, TOMOYUKI</au><au>KAWAI, SHIGETO</au><au>NAKANO, KIYOTAKA</au><au>TSUNODA, HIROYUKI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-GLYPICAN 3 ANTIBODY</title><date>2014-04-01</date><risdate>2014</risdate><abstract>An antibody capable of binding to a specific region of glypican 3, as well as a humanized antibody created based on that antibody are disclosed. The anti-GPC3 antibody of the invention has a higher ADCC activity and CDC activity compared with those of a conventional antibody. The antibody of the present invention is useful as a cell growth inhibitor, an anticancer agent and an agent for diagnosis of cancers.
Anticorps capable de se lier à une région spécifique du glypican 3 et anticorps humanisé élaboré à partir de l'anti-corps ci-dessus. L'anticorps anti-GPC3 décrit ci-dessus, qui a des activités ADCC et CDC élevées comparées aux anticorps existants, est utile en tant qu'inhibiteur de prolifération de cellule, en tant qu'agent anticancéreux, et dans le diagnostic du cancer.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_CA2544692C |
source | esp@cenet |
subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
title | ANTI-GLYPICAN 3 ANTIBODY |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T04%3A09%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANAKA,%20MEGUMI&rft.date=2014-04-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2544692C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |